BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 2538749)

  • 1. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine.
    Gershon AA; Steinberg SP
    N Engl J Med; 1989 Apr; 320(14):892-7. PubMed ID: 2538749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group.
    Hardy I; Gershon AA; Steinberg SP; LaRussa P
    N Engl J Med; 1991 Nov; 325(22):1545-50. PubMed ID: 1658650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicentre trial of live attenuated varicella vaccine in children with leukaemia in remission.
    Gershon AA; Steinberg S; Gelb L; Galasso G; Borkowsky W; LaRussa P; Ferrara A
    Postgrad Med J; 1985; 61 Suppl 4():73-8. PubMed ID: 3014482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live attenuated varicella vaccine use in immunocompromised children and adults.
    Gershon AA; Steinberg SP; Gelb L
    Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Live attenuated varicella vaccine in healthy 12- to 24-month-old children.
    Johnson CE; Shurin PA; Fattlar D; Rome LP; Kumar ML
    Pediatrics; 1988 Apr; 81(4):512-8. PubMed ID: 2832819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live attenuated varicella vaccine in children with leukemia in remission.
    Gershon AA; Steinberg S; Galasso G; Borkowsky W; Larussa P; Ferrara A; Gelb L
    Biken J; 1984 Sep; 27(2-3):77-81. PubMed ID: 6100063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
    Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
    Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Jul; 120(1):221-31. PubMed ID: 17606582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine.
    Bernstein HH; Rothstein EP; Watson BM; Reisinger KS; Blatter MM; Wellman CO; Chartrand SA; Cho I; Ngai A; White CJ
    Pediatrics; 1993 Dec; 92(6):833-7. PubMed ID: 8233746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination of children with malignant disease against varicella.
    Slørdahl SH; Wiger D; Strømøy T; Degre M; Thørsby E; Lie SO
    Postgrad Med J; 1985; 61 Suppl 4():85-92. PubMed ID: 3014484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active immunization against varicella of children with acute leukaemia or other malignancies on maintenance chemotherapy.
    Haas RJ; Belohradsky B; Dickerhoff R; Eichinger K; Eife R; Holtmann H; Goetz O; Graubner U; Peller P
    Postgrad Med J; 1985; 61 Suppl 4():69-72. PubMed ID: 3014480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Active chickenpox vaccination of children with acute leukemia or other neoplastic diseases].
    Haas RJ; Belohradsky B; Dickerhoff R; Eichinger K; Eife R; Holtmann H; Goetz O; Graubner U; Peller P
    Klin Padiatr; 1985; 197(6):477-80. PubMed ID: 3003449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of varicella vaccine in childhood leukemia. Observation over 6 years.
    Oka T; Iseki K; Oka R; Sakuma S; Yoshioka H; Takahashi M
    Biken J; 1984 Sep; 27(2-3):103-9. PubMed ID: 6100045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of live varicella vaccine in children with acute leukemia and malignant lymphoma.
    Sato Y; Miyano T; Kawauchi K; Yokoyama M
    Biken J; 1984 Sep; 27(2-3):111-3. PubMed ID: 6100046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live attenuated varicella virus vaccine. Efficacy trial in healthy children.
    Weibel RE; Neff BJ; Kuter BJ; Guess HA; Rothenberger CA; Fitzgerald AJ; Connor KA; McLean AA; Hilleman MR; Buynak EB
    N Engl J Med; 1984 May; 310(22):1409-15. PubMed ID: 6325909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of immunity to live attenuated varicella vaccine in healthy adults.
    Ampofo K; Saiman L; LaRussa P; Steinberg S; Annunziato P; Gershon A
    Clin Infect Dis; 2002 Mar; 34(6):774-9. PubMed ID: 11830801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varicella-like illness caused by live varicella vaccine in children with acute lymphocytic leukemia.
    Brunell PA; Geiser CF; Novelli V; Lipton S; Narkewicz S
    Pediatrics; 1987 Jun; 79(6):922-7. PubMed ID: 3035478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response induced by live attenuated varicella vaccine and short term follow-up on immunity of the vaccinated children.
    Chiba Y; Miura J; Kumagai T; Nakao T
    Biken J; 1984 Sep; 27(2-3):67-71. PubMed ID: 6100061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live varicella vaccine in healthy individuals.
    Just M; Berger R; Luescher D
    Postgrad Med J; 1985; 61 Suppl 4():129-32. PubMed ID: 3014469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.